Correlation Between Salesforce and Orient Europharma

Can any of the company-specific risk be diversified away by investing in both Salesforce and Orient Europharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Orient Europharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Orient Europharma Co, you can compare the effects of market volatilities on Salesforce and Orient Europharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Orient Europharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Orient Europharma.

Diversification Opportunities for Salesforce and Orient Europharma

-0.26

Correlation Coefficient

Salesforce  Orient Europharma

Very good diversification

The 3 months correlation between Salesforce and Orient is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Orient Europharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Europharma and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Orient Europharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Europharma has no effect on the direction of Salesforce i.e., Salesforce and Orient Europharma go up and down completely randomly.

Pair Corralation between Salesforce and Orient Europharma

Considering the 90-day investment horizon Salesforce is expected to generate 1.14 times more return on investment than Orient Europharma. However, Salesforce is 1.14 times more volatile than Orient Europharma Co. It trades about 0.08 of its potential returns per unit of risk. Orient Europharma Co is currently generating about -0.03 per unit of risk. If you would invest  31,043  in Salesforce on October 8, 2024 and sell it today you would earn a total of  2,247  from holding Salesforce or generate 7.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Salesforce  vs.  Orient Europharma Co

Salesforce

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

Orient Europharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orient Europharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Orient Europharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Salesforce and Orient Europharma

The main advantage of trading using opposite Salesforce and Orient Europharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Orient Europharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Europharma will offset losses from the drop in Orient Europharma's long position.

The idea behind Salesforce and Orient Europharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.